InnoCare Issues 2.04 Million A-Shares Under Incentive Plan, Lifting Total Outstanding to 1.77 Billion

Bulletin Express08-05

InnoCare Pharma Limited reported its Monthly Return for July 2026, showing a marginal uptick in outstanding shares driven by restricted-share incentives, while its authorised capital and Hong Kong-listed share count remained unchanged.

Authorised Capital • Authorised share capital stayed at 25.00 billion ordinary shares with a par value of USD0.000002, equivalent to USD50,000.

Hong Kong-Listed Shares • Issued Hong Kong shares (excluding treasury) held steady at 1.49 billion. • Treasury stock was unchanged at 2.49 million shares. • The company confirmed compliance with the Main Board’s 25% minimum public-float requirement.

Mainland-Listed (STAR Market) Shares • Issued A-shares rose by 2.04 million during the month, reaching 272.82 million. • The increase stemmed from grants under the 2023 RMB Share Incentive Scheme.

Aggregate Share Count Combining both Hong Kong and STAR Market tranches, total issued shares (excluding treasury) expanded to 1.77 billion, an incremental dilution of approximately 0.12% for the month.

Incentive Scheme Pipeline • 2023 RMB Share Incentive Scheme: 2.46 million shares remain available for future grants. • 2024 RMB Share Incentive Scheme: up to 9.68 million shares can still be issued. • 2026 RMB Share Incentive Scheme: up to 7.99 million shares remain unallocated.

No movements were recorded in share options, warrants, convertibles, or treasury shares during July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1198615330?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-05 18:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1198615330","market":"us","top_or_hot":-1,"title":"InnoCare Issues 2.04 Million A-Shares Under Incentive Plan, Lifting Total Outstanding to 1.77 Billion","media":"Bulletin Express","content":"<p>InnoCare Pharma Limited reported its Monthly Return for July 2026, showing a marginal uptick in outstanding shares driven by restricted-share incentives, while its authorised capital and Hong Kong-listed share count remained unchanged.</p>\n<p>Authorised Capital  \n• Authorised share capital stayed at 25.00 billion ordinary shares with a par value of USD0.000002, equivalent to USD50,000.</p>\n<p>Hong Kong-Listed Shares  \n• Issued Hong Kong shares (excluding treasury) held steady at 1.49 billion.  \n• Treasury stock was unchanged at 2.49 million shares.  \n• The company confirmed compliance with the Main Board’s 25% minimum public-float requirement.</p>\n<p>Mainland-Listed (STAR Market) Shares  \n• Issued A-shares rose by 2.04 million during the month, reaching 272.82 million.  \n• The increase stemmed from grants under the 2023 RMB Share Incentive Scheme.</p>\n<p>Aggregate Share Count  \nCombining both Hong Kong and STAR Market tranches, total issued shares (excluding treasury) expanded to 1.77 billion, an incremental dilution of approximately 0.12% for the month.</p>\n<p>Incentive Scheme Pipeline  \n• 2023 RMB Share Incentive Scheme: 2.46 million shares remain available for future grants.  \n• 2024 RMB Share Incentive Scheme: up to 9.68 million shares can still be issued.  \n• 2026 RMB Share Incentive Scheme: up to 7.99 million shares remain unallocated.</p>\n<p>No movements were recorded in share options, warrants, convertibles, or treasury shares during July 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>InnoCare Issues 2.04 Million A-Shares Under Incentive Plan, Lifting Total Outstanding to 1.77 Billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInnoCare Issues 2.04 Million A-Shares Under Incentive Plan, Lifting Total Outstanding to 1.77 Billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-05 18:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>InnoCare Pharma Limited reported its Monthly Return for July 2026, showing a marginal uptick in outstanding shares driven by restricted-share incentives, while its authorised capital and Hong Kong-listed share count remained unchanged.</p>\n<p>Authorised Capital  \n• Authorised share capital stayed at 25.00 billion ordinary shares with a par value of USD0.000002, equivalent to USD50,000.</p>\n<p>Hong Kong-Listed Shares  \n• Issued Hong Kong shares (excluding treasury) held steady at 1.49 billion.  \n• Treasury stock was unchanged at 2.49 million shares.  \n• The company confirmed compliance with the Main Board’s 25% minimum public-float requirement.</p>\n<p>Mainland-Listed (STAR Market) Shares  \n• Issued A-shares rose by 2.04 million during the month, reaching 272.82 million.  \n• The increase stemmed from grants under the 2023 RMB Share Incentive Scheme.</p>\n<p>Aggregate Share Count  \nCombining both Hong Kong and STAR Market tranches, total issued shares (excluding treasury) expanded to 1.77 billion, an incremental dilution of approximately 0.12% for the month.</p>\n<p>Incentive Scheme Pipeline  \n• 2023 RMB Share Incentive Scheme: 2.46 million shares remain available for future grants.  \n• 2024 RMB Share Incentive Scheme: up to 9.68 million shares can still be issued.  \n• 2026 RMB Share Incentive Scheme: up to 7.99 million shares remain unallocated.</p>\n<p>No movements were recorded in share options, warrants, convertibles, or treasury shares during July 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09969","symbol_name":"诺诚健华","start_time":0,"source_url":"","article_id":"1198615330","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1198615330","pubTimestamp":1785924424,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"InnoCare Pharma Limited reported its Monthly Return for July 2026, showing a marginal uptick in outstanding shares driven by restricted-share incentives, while its authorised capital and Hong...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09969":"诺诚健华"},"translate_title":"诺诚健华根据激励计划发行204万股A股，流通股总额达到17.7亿股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09969":1},"content_text":"InnoCare Pharma Limited reported its Monthly Return for July 2026, showing a marginal uptick in outstanding shares driven by restricted-share incentives, while its authorised capital and Hong Kong-listed share count remained unchanged.\nAuthorised Capital  \n• Authorised share capital stayed at 25.00 billion ordinary shares with a par value of USD0.000002, equivalent to USD50,000.\nHong Kong-Listed Shares  \n• Issued Hong Kong shares (excluding treasury) held steady at 1.49 billion.  \n• Treasury stock was unchanged at 2.49 million shares.  \n• The company confirmed compliance with the Main Board’s 25% minimum public-float requirement.\nMainland-Listed (STAR Market) Shares  \n• Issued A-shares rose by 2.04 million during the month, reaching 272.82 million.  \n• The increase stemmed from grants under the 2023 RMB Share Incentive Scheme.\nAggregate Share Count  \nCombining both Hong Kong and STAR Market tranches, total issued shares (excluding treasury) expanded to 1.77 billion, an incremental dilution of approximately 0.12% for the month.\nIncentive Scheme Pipeline  \n• 2023 RMB Share Incentive Scheme: 2.46 million shares remain available for future grants.  \n• 2024 RMB Share Incentive Scheme: up to 9.68 million shares can still be issued.  \n• 2026 RMB Share Incentive Scheme: up to 7.99 million shares remain unallocated.\nNo movements were recorded in share options, warrants, convertibles, or treasury shares during July 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1198615330","isCrawlerRequest":true}